The medication schedule follows this progression: Week 1-4: 0.25 mg weekly dose Week 5 onwards: 0.5 mg weekly dose Further adjustments to 1 mg or 2 mg based on individual needs Patients may take their dose with or without food, offering flexibility around mealtimes
What a great place
We use clinical photography (front, three-quarter, profile, under cross-polarized light) to document the baseline, the four-week milestone, and the three-month outcome so progress is measurable rather than felt
Cch dng: Ung 1-2 vin mi ngy sau ba n, c th ung vi nc lc hoc nc tri cy
Renal Impairment The effect of renal impairment on the pharmacokinetics of TOUJEO has not been studied
While the NIH does not specify a tolerable upper intake level for vitamin B12, a study published in the JAMA Network Open found that high intakes of vitamin B12, such as from daily supplementation of 25 micrograms or higher, increased the risk of bone fracture [3] [4]